Movement Disorders

Investigating the molecular and cellular mechanisms behind alpha-synuclein aggregation in Parkinson’s disease and dementia with Lewy bodies. Using in vitro, cell culture and in vivo models, the lab aims to uncover how toxic protein forms drive neurodegeneration and to develop better diagnostics and treatments for synucleinopathies.

Research profile

Advances research on neurodegenerative diseases, focusing on Parkinson’s disease and infantile neuroaxonal dystrophy. The lab investigates alpha-synuclein aggregation, neuronal connectivity and enzyme dysfunction to develop imaging tools and treatments that slow disease progression and improve diagnosis.

Research profile

Investigating movement disorders like Parkinson’s disease and dystonia. Through neuroimaging, deep brain stimulation studies and translational research, the lab explores brain physiology, develops biomarkers and tests therapies to improve diagnosis, treatment and understanding of these conditions.

Research profile